Aroa Biosurgery Limited (ASX: ARX)
Australia
· Delayed Price · Currency is AUD 0.720
+0.020 (2.86%)
Dec 4, 2024, 4:10 PM AEST
Aroa Biosurgery Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
| Revenue | 76.35 | 69.07 | 63.36 | 39.68 | 22.34 | 25.08 | Upgrade
|
| Revenue Growth (YoY) | 15.87% | 9.01% | 59.68% | 77.60% | -10.90% | 3.67% | Upgrade
|
| Cost of Revenue | 10.21 | 10.09 | 9.88 | 9.38 | 6.82 | 6.34 | Upgrade
|
| Gross Profit | 66.15 | 58.97 | 53.48 | 30.3 | 15.52 | 18.74 | Upgrade
|
| Selling, General & Admin | 67.91 | 62.15 | 47.71 | 30.71 | 21.76 | 16.67 | Upgrade
|
| Research & Development | 9.42 | 9.16 | 10.61 | 8.35 | 6.43 | 5.04 | Upgrade
|
| Other Operating Expenses | -1.29 | -1.66 | -1.73 | -1.12 | -2.68 | -0.13 | Upgrade
|
| Operating Expenses | 76.05 | 69.64 | 56.59 | 37.95 | 25.5 | 21.58 | Upgrade
|
| Operating Income | -9.9 | -10.67 | -3.11 | -7.64 | -9.98 | -2.84 | Upgrade
|
| Interest Expense | -0.51 | -0.49 | -0.38 | -1.15 | -1.91 | -2.97 | Upgrade
|
| Interest & Investment Income | 1.5 | 1.8 | 1.32 | 0.4 | 0.15 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.75 | -1.05 | 1.8 | 0.13 | 0.65 | -0.35 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.01 | -0.01 | -0 | -0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -7.17 | -10.43 | -0.38 | -8.26 | -11.09 | -6.16 | Upgrade
|
| Other Unusual Items | - | - | - | - | -8.01 | - | Upgrade
|
| Pretax Income | -7.17 | -10.43 | -0.38 | -8.26 | -19.1 | -6.16 | Upgrade
|
| Income Tax Expense | 0.45 | 0.2 | 0.01 | 0.13 | 0.11 | -0.2 | Upgrade
|
| Net Income | -7.62 | -10.63 | -0.4 | -8.39 | -19.21 | -5.96 | Upgrade
|
| Net Income to Common | -7.62 | -10.63 | -0.4 | -8.39 | -19.21 | -5.96 | Upgrade
|
| Shares Outstanding (Basic) | 344 | 344 | 343 | 342 | 300 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 344 | 344 | 343 | 342 | 300 | 3 | Upgrade
|
| Shares Change (YoY) | 0.35% | 0.26% | 0.22% | 13.90% | 10620.95% | -94.22% | Upgrade
|
| EPS (Basic) | -0.02 | -0.03 | -0.00 | -0.02 | -0.06 | -2.13 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.03 | -0.00 | -0.02 | -0.06 | -2.13 | Upgrade
|
| Free Cash Flow | -7.92 | -10.9 | -9.8 | -15.98 | -6.27 | -0.03 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.03 | -0.05 | -0.02 | -0.01 | Upgrade
|
| Gross Margin | 86.63% | 85.39% | 84.40% | 76.37% | 69.48% | 74.72% | Upgrade
|
| Operating Margin | -12.97% | -15.45% | -4.91% | -19.26% | -44.66% | -11.34% | Upgrade
|
| Profit Margin | -9.97% | -15.39% | -0.63% | -21.13% | -85.98% | -23.76% | Upgrade
|
| Free Cash Flow Margin | -10.37% | -15.78% | -15.47% | -40.26% | -28.07% | -0.12% | Upgrade
|
| EBITDA | -6.51 | -7.3 | -0.08 | -5.29 | -7.67 | -0.56 | Upgrade
|
| EBITDA Margin | -8.53% | -10.57% | -0.13% | -13.32% | -34.33% | -2.22% | Upgrade
|
| D&A For EBITDA | 3.39 | 3.37 | 3.03 | 2.36 | 2.31 | 2.29 | Upgrade
|
| EBIT | -9.9 | -10.67 | -3.11 | -7.64 | -9.98 | -2.84 | Upgrade
|
| EBIT Margin | -12.97% | -15.45% | -4.91% | -19.26% | -44.66% | -11.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.